Holen Sie sich die Stockscreener-App
92.97
0.98%
0.8681
Schlusskurs vom Vortag:
$92.10
Offen:
$92.37
24-Stunden-Volumen:
82,210
Relative Volume:
0.82
Marktkapitalisierung:
$1.19B
Einnahmen:
$86.28M
Nettoeinkommen (Verlust:
$23.61M
KGV:
50.64
EPS:
1.8359
Netto-Cashflow:
$23.97M
1W Leistung:
+6.46%
1M Leistung:
+4.87%
6M Leistung:
+0.18%
1J Leistung:
+82.03%
1-Tages-Spanne:
$90.97
$93.41
1-Wochen-Bereich:
$87.39
$95.47
52-Wochen-Spanne:
$51.26
$107.90
Iradimed Corp Stock (IRMD) Company Profile
Firmenname
Iradimed Corp
Sektor
Branche
Telefon
(407) 677-8022
Adresse
12705 INGENUITY DRIVE, ORLANDO
Compare IRMD vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRMD
Iradimed Corp
|
92.96 | 1.18B | 86.28M | 23.61M | 23.97M | 1.8359 |
ABT
Abbott Laboratories
|
86.64 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
312.20 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.82 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.72 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-04-12 | Eingeleitet | Lake Street | Buy |
| 2017-10-31 | Fortgesetzt | ROTH Capital | Buy |
| 2016-10-05 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2015-11-02 | Bestätigt | ROTH Capital | Buy |
| 2015-07-30 | Bestätigt | ROTH Capital | Buy |
| 2015-06-16 | Bestätigt | ROTH Capital | Buy |
| 2015-01-12 | Bestätigt | ROTH Capital | Buy |
| 2014-12-23 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Iradimed Corp Aktie (IRMD) Neueste Nachrichten
Iradimed’s CEO and Founder Sold 7,500 Company Shares. What Does That Mean for Investors? - sharewise.com
IRadimed’s Earnings Call Highlights 3870-Led Growth - TipRanks
IRMD Stock Chart | IRADIMED CORP (NASDAQ:IRMD) - ChartMill
iRadimed Corp (IRMD) Rallies 3% as Medical Device Stock Holds Key SupportOpen Market Insights - Newser
Iradimed CEO Roger Susi sells $657,264 in company stock - Investing.com
CEO’s trust sells 7,500 IRADIMED (IRMD) shares under Rule 10b5-1 plan - Stock Titan
IRADIMED CEO and CFO head to Goldman Sachs health conference in Miami - Stock Titan
Iradimed (NASDAQ: IRMD) family trusts disclose 4.45M shares, 34.8% ownership - Stock Titan
IRADIMED (IRMD) CEO Susi’s trust sells 7,500 pre-planned shares - Stock Titan
Reaffirmed Outlook And Dividend: What Does IRMD’s Confidence Signal About Its MRI Pump Moat? - Yahoo Finance
The Bull Case For IRADIMED (IRMD) Could Change Following Q1 Results And Reaffirmed 2026 GuidanceLearn Why - Sahm
Here's What We Like About IRADIMED's (NASDAQ:IRMD) Upcoming Dividend - Yahoo Finance
IRMD (iRadimed Corporation) beats Q1 estimates with 14.4% revenue growth, but shares dip despite strong results.Earnings Surprise Stocks - Newser
A Look At IRADIMED (IRMD) Valuation As Long Term Returns Contrast With Recent Share Price Weakness - Yahoo Finance
Iradimed CEO Roger Susi sells $642,861 in company stock By Investing.com - Investing.com South Africa
Iradimed CEO Roger Susi sells $642,861 in company stock - Investing.com
IRADIMED (IRMD) CEO-linked trust sells 7,500 shares under 10b5-1 plan - Stock Titan
Is IRADIMED’s 3870 Pump Launch And Reaffirmed Outlook Altering The Investment Case For IRMD? - Sahm
IRadimed Corporation (NASDAQ:IRMD) Q1 2026 Earnings Call Transcript - Insider Monkey
A Look At IRADIMED (IRMD) Valuation After Q1 2026 Growth, New Pump Rollout And Dividend - Sahm
IRadimed Rides 3870 Momentum Despite Near-Term Dip - TipRanks
IRMD (iRadimed Corporation) tops Q1 2026 EPS estimates by 8 percent, shares rise 4.45 percent in today’s session.Open Stock Signal Network - Newser
iRadimed (NASDAQ:IRMD) Issues Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
IRadimed Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
iRadimed Corporation (NASDAQ:IRMD) Given Consensus Rating of "Buy" by Analysts - MarketBeat
iRadimed Corp (IRMD) Q1 2026 Earnings Call Highlights: Strong Re - GuruFocus
Why Iradimed Stock Topped the Market Today - Yahoo Finance
iRadimed Corp (IRMD) Shares Surge 4.4% -- What GF Score of 95 Te - GuruFocus
iRadimed Corporation (NASDAQ:IRMD) Plans Quarterly Dividend of $0.20 - MarketBeat
IRADIMED CORPORATION Files Form 8-K with SEC for May 2026 – Company Information, Address, and Stock Exchange Details - Minichart
IRADIMED CORP 1Q 2026: Revenue $21.98M, EPS $0.45— 10-Q Summary - TradingView
IRADIMED (NASDAQ: IRMD) Q1 2026 revenue rises 13% to $22M - Stock Titan
iRadimed (NASDAQ:IRMD) Sees Large Volume IncreaseShould You Buy? - MarketBeat
iRadimed Q1 Earnings Call Highlights - MarketBeat
Earnings call transcript: Iradimed Co beats Q1 2026 expectations, stock dips - Investing.com
iRadimed (IRMD) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
IRadimed Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Iradimed reports Q1 2026 revenue $22.0M, GAAP EPS $0.45; declares $0.20 quarterly dividend - TradingView
iRadimed (NASDAQ:IRMD) Updates FY 2026 Earnings Guidance - MarketBeat
iRadimed (NASDAQ:IRMD) Issues Q2 2026 Earnings Guidance - MarketBeat
IRADIMED ($IRMD) Releases Q1 2026 Earnings - Quiver Quantitative
IRADIMED (NASDAQ: IRMD) Q1 growth, dividend and 2026 outlook - Stock Titan
IRadimed: Q1 Earnings Snapshot - WKYC
MRI device maker IRADIMED launches new pump as Q1 sales climb 13% - Stock Titan
Roger Susi Sells 3,750 Shares of iRadimed (NASDAQ:IRMD) Stock - MarketBeat
Executive pay and director votes at Iradimed (NASDAQ: IRMD) 2026 meeting - Stock Titan
Iradimed CEO Susi’s trust sells $657,709 in company stock By Investing.com - Investing.com Australia
Iradimed CEO Susi’s trust sells $657,709 in company stock - Investing.com
How The Evolving Story For IRADIMED (IRMD) Is Shaping Analyst Targets And Fair Value - Yahoo Finance
Iradimed's CEO Dumped 7,500 Shares. Here's What That Means for Investors. - The Motley Fool
Iradimed's CEO Dumped 7,500 Shares. Here's What That Means for Investors. - The Motley Fool
Finanzdaten der Iradimed Corp-Aktie (IRMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Iradimed Corp-Aktie (IRMD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Susi Roger E. | CEO, President, Chairman |
May 19 '26 |
Sale |
87.88 |
2,500 |
219,694 |
2,172,500 |
| Susi Roger E. | CEO, President, Chairman |
May 12 '26 |
Sale |
83.92 |
4,411 |
370,183 |
2,180,000 |
| Susi Roger E. | CEO, President, Chairman |
May 11 '26 |
Sale |
84.54 |
3,089 |
261,157 |
2,184,411 |
| Susi Roger E. | CEO, President, Chairman |
May 05 '26 |
Sale |
85.74 |
3,750 |
321,529 |
2,187,500 |
| Susi Roger E. | CEO, President, Chairman |
May 04 '26 |
Sale |
85.69 |
3,750 |
321,333 |
2,191,250 |
| Susi Roger E. | CEO, President, Chairman |
Apr 27 '26 |
Sale |
89.16 |
3,750 |
334,345 |
2,198,750 |
| Susi Roger E. | CEO, President, Chairman |
Apr 28 '26 |
Sale |
86.23 |
3,750 |
323,364 |
2,195,000 |
| Susi Roger E. | CEO, President, Chairman |
Apr 20 '26 |
Sale |
93.36 |
5,000 |
466,779 |
2,205,000 |
| Susi Roger E. | CEO, President, Chairman |
Apr 21 '26 |
Sale |
90.94 |
2,500 |
227,345 |
2,202,500 |
| Susi Roger E. | CEO, President, Chairman |
Apr 13 '26 |
Sale |
92.52 |
5,000 |
462,584 |
2,212,500 |
0.32%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):